查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390742

精准医疗市场报告产品、技术、应用（肿瘤学、中枢神经系统、免疫学、呼吸医学、感染等）、最终用户和地区 2023-2028

Precision Medicine Market Report Product, Technology, Application (Oncology, Central Nervous System, Immunology, Respiratory Medicine, Infections, and Others), End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球精准医疗市场规模达681亿美元。展望未来， IMARC Group预计到2028年市场规模将达到1,234亿美元，2022-2028年复合年增长率（CAGR）为10.41%。快速的技术进步、研发投资、不断增长的消费者需求、有利的政府政策的实施、电子健康记录（EHR）的激增、製药公司之间的战略联盟、慢性病的增加是推动这一趋势的主要因素。市场。

精准医疗，也称为个人化医疗，是一种在做出医疗决策时考虑个人独特的基因组成、环境和生活方式的医疗保健方法。它涉及根据每位患者的具体特征制定医疗治疗和干预措施，而不是使用一刀切的方法。精准医学依靠基因组学和其他生物医学研究领域的进步来识别遗传变异和生物标记物，帮助预测患者对某些药物或疗法的反应。

基因组学、生物资讯学和医学影像领域的持续创新为精准医疗提供了必要的工具，从而推动了市场的成长。除此之外，政府和私营部门对研发（R＆D）的投资正在加快精准医疗的发现和实施步伐，从而推动市场成长。与此相适应，更知情和具有健康意识的公众正在寻求个人化的医疗解决方案，从而推动市场向前发展。除此之外，各国政府越来越认识到精准医疗的潜力，制定政策和法规，促进其采用和标准化，从而有利于市场成长。此外，电子健康记录（EHR）和其他健康资料存储库的激增使医疗保健提供者更容易访问和分析患者信息，进一步促进了市场扩张。

精准医学市场趋势/驱动因素：

技术进步

科技在精准医疗市场中的作用是不可否认的，目前是其成长的主要驱动力之一。基因组学、生物资讯学和医学影像领域的创新使得以前所未有的准确性分析和解释大量生物资料成为可能。最新的定序技术可以进行更快速、更具成本效益的基因分析，让个人化治疗更容易实现。生物资讯工具提供强大的演算法来解释复杂的遗传讯息，为临床医生提供可行的见解。磁振造影 (MRI) 和电脑断层扫描 (CT) 等医学影像技术也在不断发展，可以显示最微小的细节，有助于诊断和治疗计划。这些技术突破正在产生连锁反应，不仅推动了医学科学的发展，也推动了精准医疗市场的发展。

实施各项政府措施并增加资金

资金是推动精准医疗市场的重要催化剂。除此之外，政府和私营部门的财政支持正在加快研发 (R&D) 的步伐，使得探索个人化医疗保健的新途径成为可能。大型计画（通常是国际合作）正在启动，以揭示各种疾病的潜在遗传和环境因素。专注于开发精准医疗技术或方法的新创公司和研究机构可以获得赠款和补贴。资本的涌入正在加速新产品和服务的商业化，将市场推向更高的高度。

群众健康意识不断增强

知情且具有健康意识的人群正在创造对个人化医疗解决方案的强劲需求，从而成为精准医疗市场的关键驱动力。随着医疗资讯的获取越来越多，患者正在成为医疗保健旅程的积极参与者，寻求更有针对性和更有效的治疗。社群媒体和线上平台正在扩大医学突破的影响范围，使患者能够寻求量身定制的治疗方法。消费者行为的转变迫使医疗保健提供者和製药公司透过开发更个人化的解决方案来适应这些需求。这反过来又产生了需求和供应的循环，从而推动了市场扩张。

精准医疗产业细分：

IMARC Group提供了全球精准医疗市场报告各细分市场主要趋势的分析，以及 2023-2028 年全球、区域和国家层面的预测。我们的报告根据产品、技术、应用和最终用户对市场进行了分类。

按产品划分：

耗材

仪器

服务

该报告根据产品类型对市场进行了详细的细分和分析。这包括消耗品、仪器和服务。

耗材在精准医疗市场的应用主要出于关键零件、高需求、研发、成本效益、客製化和持续创新等几个原因。

由于技术进步、个人化诊断、药物开发、研究应用、成本降低、监管支援、意识增强和市场竞争力等几个引人注目的因素，仪器为精准医疗市场提供了帮助。

由于客製化和个人化、资料分析专业知识、监管合规性、快速技术进步、整体患者护理、专业设备的使用、跨学科合作、品质保证和标准化、长期参与等多种原因，服务被用于精准医疗市场。资料安全和隐私以及成本效率。

按技术划分：

大数据分析

生物资讯学

基因定序

药物发现

伴随诊断

其他的

药物发现占据最大市场份额

报告还提供了基于该技术的详细市场细分和分析。这包括巨量资料分析、生物资讯学、基因定序、药物发现、伴随诊断等。报告称，药物发现占据了最大的市场份额。

药物发现目前在精准医学市场的技术领域占据主导地位，因为它在开发标靶疗法方面发挥关键作用，而标靶疗法是精准医学的基石。透过利用先进的基因组学和生物资讯学，药物发现已从广谱方法转变为高度客製化的方法，旨在开发更有效且副作用更少的治疗方法。这直接影响临床试验的成功率，以及新药的整体成本和上市时间。此外，现代药物发现中使用的高通量筛选方法和人工智慧（AI）驱动的演算法可以分析大量资料集的模式或标记，从而大大加快寻找合适候选药物的过程。

按应用划分：

肿瘤学

中枢神经系统 (CNS)

免疫学

呼吸内科

感染

其他的

肿瘤学占据最大市场份额

报告还提供了基于应用程式的详细市场细分和分析。这包括肿瘤学、中枢神经系统 (CNS)、免疫学、呼吸系统医学、感染学等。报告称，肿瘤学占据最大的市场份额。

由于多种因素使其特别适合个人化治疗方法，肿瘤学目前在精准医疗市场的应用领域中占据主导地位。癌症是一种高度异质性的疾病，即使在同一类型的癌症中，也具有不同的基因突变。精准医学可以识别癌细胞中的特定遗传标记和突变，使临床医生能够开出更有可能成功的标靶治疗。此外，全球癌症的高盛行率需要创新和有效的治疗策略，从而推动肿瘤学精准医学的需求。基因组定序技术的进步也促进了致癌突变的快速识别，加速了标靶药物和个人化治疗计划的开发。此外，癌症研究正在进行大量投资，为在肿瘤学中广泛应用精准医学提供所需的财政支持。因此，癌症生物学的复杂性加上技术和财务因素使肿瘤学成为精准医疗市场中最突出的领域。

按最终用户划分：

医院和诊所

诊断中心

製药和生物技术公司

医疗保健 IT 公司

其他的

医院和诊所占据最大的市场份额

报告还提供了基于最终用户的详细市场细分和分析。这包括医院和诊所、诊断中心、製药和生物技术公司、医疗保健 IT 公司等。报告显示，医院和诊所占据了最大的市场。

由于多种因素的综合作用，医院和诊所目前在精准医疗市场的最终用户领域占据主导地位，这些因素使得这些环境特别适合实施个人化医疗保健解决方案。医院和诊所拥有精准医疗所需的基础设施和先进医疗技术，例如专业诊断设备和先进的资料分析平台。此外，这些机构受益于多学科团队的专业知识，包括遗传学家、资料科学家和专业临床医生，他们可以协作解释复杂的资料以指导治疗计划。此外，医院和诊所的患者数量和多样性为在各种条件和人口统计中应用精准医疗提供了更广泛的范围，从而为持续改进和研究提供了强大的数据集。这些要素共同创造了一个有利于精准医疗的采用和成功实施的生态系统，从而有助于医院和诊所在市场上的主导地位。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美占据明显主导地位，占据最大的精准医疗市场份额

市场研究报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美占据最大的市场份额。

由于创造了有利于成长的环境的因素的综合作用，北美目前在精准医疗市场的区域领域处于领先地位。该地区拥有强大的医疗基础设施，配备最先进的医疗技术和研究设施。政府和私营部门的大量资金进一步支持了这一点，为精准医疗领域的研究和发展提供了充足的资源。尤其是美国，一直透过精准医疗倡议等立法措施积极支持精准医疗，从而促进创新和标准化。此外，北美拥有高水准的消费者医疗保健意识和教育水准。民众精通科技且注重健康，推动了对更个人化医疗解决方案的需求。所有这些因素共同促成了北美在全球精准医疗领域的主导地位。

竞争格局：

精准医疗市场的领导者正在积极参与各种策略性倡议，旨在巩固其市场地位并推动创新。研究与开发 (R&D) 仍然是其活动的基石，为发现新疗法和诊断工具分配了大量投资。其中许多公司还与学术机构、生技公司和医疗保健提供者建立合作和伙伴关係，以加快进步的步伐。此外，随着大型企业寻求将尖端技术整合到其现有产品组合中，併购变得越来越普遍。这些多方面的努力凸显了领导企业对塑造精准医疗未来格局的承诺。

该报告对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

阿斯特捷利康公司

拜耳公司

生物梅里埃公司

百时美施贵宝公司

礼来公司

F.霍夫曼-拉罗氏股份公司

照明公司

美国实验室控股公司

默克公司

诺华公司

辉瑞公司

凯杰公司

奎斯特诊断公司

赛默飞世尔科技公司

最近的发展：

2023年2月，罗氏宣布扩大与杨森生物技术公司（Janssen）的合作，为标靶治疗创建伴随诊断，进一步加强研究和创新活动。

2021 年 12 月，Illumina, Inc. 宣布支持挪威的一项国家精准医学研究，以评估基于血液的综合基因组分析 (CGP) 在癌症治疗选择测试中的功效。

2020 年5 月，QIAGEN 推出了新型QIAseq Targeted Mmethyl panel，这是首款也是唯一一款基于NGS 的标靶甲基化分析产品，该产品透过公司专有的单引物延伸技术提高了分析灵敏度和序列靶向能力。

本报告回答的关键问题：

  • 迄今为止，全球精准医疗市场表现如何，未来几年将如何表现？
  • 全球精准医疗市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球精准医疗市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的精准医疗市场？
  • 基于产品的市场区隔是什么？
  • 精准医疗市场最有吸引力的产品是什么？
  • 什么是基于技术的市场分割？
  • 精准医疗市场最有吸引力的技术是什么？
  • 基于应用程式的市场区隔是什么？
  • 精准医疗市场最具吸引力的应用是什么？
  • 基于最终用户的市场区隔是什么？
  • 正畸耗材市场上哪一个对最终用户最具吸引力？
  • 全球精准医疗市场竞争格局如何？
  • 全球精准医疗市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 迄今为止，全球精准医疗市场表现如何，未来几年将如何表现？
  • 全球精准医疗市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球精准医疗市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的精准医疗市场？
  • 基于产品的市场区隔是什么？
  • 精准医疗市场最有吸引力的产品是什么？
  • 什么是基于技术的市场分割？
  • 精准医疗市场最有吸引力的技术是什么？
  • 基于应用程式的市场区隔是什么？
  • 精准医疗市场最具吸引力的应用是什么？
  • 基于最终用户的市场区隔是什么？
  • 正畸耗材市场上哪一个对最终用户最具吸引力？
  • 全球精准医疗市场竞争格局如何？
  • 全球精准医疗市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球精准医疗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按产品分類的市场区隔

  • 耗材
    • 市场走向
    • 市场预测
  • 仪器
    • 市场走向
    • 市场预测
  • 服务
    • 市场走向
    • 市场预测

第 7 章：依科技分類的市场

  • 大数据分析
    • 市场走向
    • 市场预测
  • 生物资讯学
    • 市场走向
    • 市场预测
  • 基因定序
    • 市场走向
    • 市场预测
  • 药物发现
    • 市场走向
    • 市场预测
  • 伴随诊断
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按应用分類的市场区隔

  • 肿瘤学
    • 市场走向
    • 市场预测
  • 中枢神经系统 (CNS)
    • 市场走向
    • 市场预测
  • 免疫学
    • 市场走向
    • 市场预测
  • 呼吸内科
    • 市场走向
    • 市场预测
  • 感染
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：最终用户的市场区隔

  • 医院和诊所
    • 市场走向
    • 市场预测
  • 诊断中心
    • 市场走向
    • 市场预测
  • 製药和生物技术公司
    • 市场走向
    • 市场预测
  • 医疗保健 IT 公司
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AstraZeneca plc
    • Bayer AG
    • bioMerieux SA
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Qiagen NV
    • Quest Diagnostics Incorporated
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A4567

Abstract

The global precision medicine market size reached US$ 68.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 123.4 Billion by 2028, exhibiting a growth rate (CAGR) of 10.41% during 2022-2028. Rapid technological advancements, investments in research and development(R&D), increasing consumer demand, the implementation of favorable government policies, surge in electronic health records (EHRs), strategic alliances between pharmaceutical companies, rising chronic diseases are some of the major factors propelling the market.

Precision medicine, also known as personalized medicine, is an approach to healthcare that takes into account an individual's unique genetic makeup, environment, and lifestyle when making medical decisions. It involves tailoring medical treatments and interventions to the specific characteristics of each patient, rather than using a one-size-fits-all approach. Precision medicine relies on advancements in genomics and other fields of biomedical research to identify genetic variations and biomarkers that can help predict a patient's response to certain drugs or therapies.

Ongoing innovations in genomics, bioinformatics, and medical imaging are providing the essential tools for precision medicine, thereby driving the market growth. In addition to this, government and private sector investments in research and development (R&D) are accelerating the pace of discoveries and implementation in precision medicine which in turn is impelling the market growth. In line with this, a more informed and health-conscious public is seeking personalized medical solutions, thus propelling the market forward. Besides this, governments are increasingly recognizing the potential of precision medicine, enacting policies and regulations that facilitate its adoption and standardization thus favoring the market growth. Furthermore, the surge in electronic health records (EHRs) and other health data repositories has made it easier for healthcare providers to access and analyze patient information, further catalyzing market expansion.

Precision Medicine Market Trends/Drivers:

Technological advancements

The role of technology in the precision medicine market is undeniable and currently serves as one of the primary drivers for its growth. Innovations in genomics, bioinformatics, and medical imaging are making it possible to analyze and interpret vast amounts of biological data with unprecedented accuracy. The latest sequencing technologies allow for more rapid and cost-effective genetic analysis, thereby making personalized treatment more accessible. Bioinformatics tools offer robust algorithms to interpret complex genetic information, providing actionable insights for clinicians. Medical imaging techniques like magnetic resonance imaging (MRI) and computerized tomography (CT) scans are also evolving to show even the most minute details, helping in the diagnosis and treatment planning. These technological breakthroughs are creating a ripple effect, advancing not just medical science but also propelling the precision medicine market forward.

The implementation of various government initiatives and increased funding

Funding serves as a significant catalyst in driving the precision medicine market. In addition to this, financial backing from both the government and private sectors is accelerating the pace of research and development (R&D), making it possible to explore new avenues in personalized healthcare. Large-scale projects, often international collaborations, are being initiated to uncover the underlying genetic and environmental factors of various diseases. Grants and subsidies are available for startups and research institutions that focus on developing precision medicine technologies or methodologies. This influx of capital is speeding up the commercialization of new products and services, thereby pushing the market towards greater heights.

The rising health consciousness among the masses

An informed and health-conscious population is creating robust demand for personalized medical solutions, thereby acting as a key driver for the precision medicine market. With increasing access to medical information, patients are becoming active participants in their healthcare journey, seeking more targeted and efficient treatments. Social media and online platforms are amplifying the reach of medical breakthroughs, empowering patients to ask for tailored therapies. The shift in consumer behavior is compelling healthcare providers and pharmaceutical companies to adapt to these demands by developing more personalized solutions. This in turn is generating a cycle of demand and supply that is fueling market expansion.

Precision Medicine Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global precision medicine market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product, technology, application and end user.

Breakup by Product:

Consumables

Instruments

Services

The report has provided a detailed breakup and analysis of the market based on the product type. This includes consumables, instruments, and services.

Consumables are used in precision medicine market due to several reasons such as essential components, high demand, research and development, cost-effectiveness, customization, and continuous innovation.

Instruments assist the precision medicine market due to several compelling factors such as technological advancements, personalized diagnostics, drug development, research applications, cost reduction, regulatory support, increased awareness and market competitiveness.

Services are used in precision medicine market due to several reasons such as customization and personalization, data analysis expertise, regulatory compliance, rapid technological advancements, holistic patient care, access to specialized equipment, interdisciplinary collaboration, quality assurance and standardization, long-term engagement, data security and privacy, and cost efficiency.

Breakup by Technology:

Big Data Analytics

Bioinformatics

Gene Sequencing

Drug Discovery

Companion Diagnostics

Others

Drug discovery hold the largest share in the market

A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others. According to the report, drug discovery accounted for the largest market share.

Drug discovery currently dominates the technology segment of the precision medicine market due to its critical role in developing targeted therapies, which are the cornerstone of precision medicine. By leveraging advanced genomics and bioinformatics, drug discovery has moved from a broad-spectrum approach to one that is highly tailored, aiming to develop treatments that are more effective and have fewer side effects. This has a direct impact on the rate of successful clinical trials, as well as the overall cost and time-to-market for new drugs. Furthermore, the high throughput screening methods and artificial intelligence (AI) driven algorithms used in modern drug discovery can analyze enormous data sets for patterns or markers, dramatically speeding up the process of finding suitable drug candidates.

Breakup by Application:

Oncology

Central Nervous System (CNS)

Immunology

Respiratory Medicine

Infections

Others

Oncology holds the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes oncology, central nervous system (CNS), immunology, respiratory medicine, infections, and others. According to the report, oncology accounted for the largest market share.

Oncology is currently dominating the application segment of the precision medicine market due to a confluence of factors that make it particularly suited for personalized treatment approaches. Cancer is a highly heterogeneous disease with varying genetic mutations, even within the same type of cancer. Precision medicine allows for the identification of specific genetic markers and mutations in cancer cells, enabling clinicians to prescribe targeted therapies that are more likely to succeed. Additionally, the high prevalence of cancer across the globe necessitates innovative and effective treatment strategies, thereby driving demand for precision medicine in oncology. Advances in genomic sequencing technologies have also facilitated the rapid identification of oncogenic mutations, accelerating the development of targeted drugs and personalized treatment plans. Furthermore, significant investments are being made in cancer research, providing the financial backing needed to apply precision medicine widely in oncology. Hence, the intricacies of cancer biology combined with technological and financial factors make oncology the most prominent sector within the precision medicine market.

Breakup by End User:

Hospitals and Clinics

Diagnostic Centers

Pharma and Biotech Companies

Healthcare IT Firms

Others

Hospitals and clinics hold the largest share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals and clinics, diagnostic centers, pharma and biotech companies, healthcare IT firms, and others. According to the report, hospitals and clinics accounted for the largest market share.

Hospitals and clinics are currently dominating the end-user segment of the precision medicine market due to a confluence of factors that make these settings particularly suited for implementing personalized healthcare solutions. Hospitals and clinics have the infrastructure and access to advanced medical technologies that are essential for precision medicine, such as specialized diagnostic equipment and advanced data analytics platforms. Moreover, these institutions benefit from the expertise of multidisciplinary teams, including geneticists, data scientists, and specialized clinicians, who can collaboratively interpret complex data to guide treatment plans. Furthermore, the patient volume and diversity present in hospitals and clinics offer a broader scope for applying precision medicine across various conditions and demographics, thus providing a robust dataset for continuous improvement and research. Together, these elements create an ecosystem that is conducive to the adoption and successful implementation of precision medicine, thereby contributing to the domination of hospitals and clinics in the market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest precision medicine market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is currently leading the regional segment of the precision medicine market due to a confluence of factors that create an environment conducive for growth. The region is home to a robust healthcare infrastructure, equipped with state-of-the-art medical technologies and research facilities. This is further supported by substantial funding from both governmental and private sectors, providing ample resources for research and development in the field of precision medicine. The United States, in particular, has been proactive in endorsing precision medicine through legislative measures, such as the Precision Medicine Initiative, thereby fostering innovation and standardization. Additionally, North America boasts a high level of consumer awareness and education regarding healthcare. The populace is technologically savvy and health-conscious, driving demand for more personalized medical solutions. All these elements collectively contribute to North America's dominant position in the global landscape of precision medicine.

Competitive Landscape:

The leading players in the precision medicine market are actively engaging in a variety of strategic initiatives aimed at consolidating their market position and driving innovation. Research and development (R&D) remain a cornerstone of their activities, with significant investments allocated for the discovery of novel therapies and diagnostic tools. Many of these companies are also entering into collaborations and partnerships with academic institutions, biotechnology firms, and healthcare providers to accelerate the pace of advancements. Furthermore, mergers and acquisitions are becoming increasingly common as larger players seek to integrate cutting-edge technologies into their existing portfolios. These multifaceted efforts underscore the commitment of leading players to shaping the future landscape of precision medicine.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AstraZeneca plc

Bayer AG

bioMerieux SA

Bristol-Myers Squibb Company

Eli Lilly and Company

F. Hoffmann-La Roche AG

Illumina Inc.

Laboratory Corporation of America Holdings

Merck KGaA

Novartis AG

Pfizer Inc.

Qiagen N.V.

Quest Diagnostics Incorporated

Thermo Fisher Scientific Inc.

Recent Developments:

In February 2023, Roche announced that it has expanded its collaboration with Janssen Biotech Inc. (Janssen) to create companion diagnostics for targeted therapies, further strengthening research and innovation activities.

In December 2021, Illumina, Inc. announced that it is supporting a national precision medicine study in Norway to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing.

In May 2020, QIAGEN has launched the novel QIAseq Targeted Methyl panels, the first and only NGS-based products for targeted methylation analysis with the increased analytical sensitivity and sequence-targeting capabilities of the company's proprietary Single Primer Extension technology.

Key Questions Answered in This Report:

  • How has the global precision medicine market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global precision medicine market?
  • What is the impact of each driver, restraint, and opportunity on the global precision medicine market?
  • What are the key regional markets?
  • Which countries represent the most attractive precision medicine market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the precision medicine market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the precision medicine market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the precision medicine market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the orthodontic consumables market?
  • What is the competitive structure of the global precision medicine market?
  • Who are the key players/companies in the global precision medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Precision Medicine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Big Data Analytics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bioinformatics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Gene Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Drug Discovery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Companion Diagnostics
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Central Nervous System (CNS)
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Immunology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Respiratory Medicine
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Infections
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharma and Biotech Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Healthcare IT Firms
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AstraZeneca plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 bioMerieux SA
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Bristol-Myers Squibb Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Eli Lilly and Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Illumina Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Laboratory Corporation of America Holdings
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Merck KGaA
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Novartis AG
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Pfizer Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Qiagen N.V.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Quest Diagnostics Incorporated
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Thermo Fisher Scientific Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Precision Medicine Market: Major Drivers and Challenges
  • Figure 2: Global: Precision Medicine Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Precision Medicine Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Precision Medicine Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Precision Medicine Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Precision Medicine Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Precision Medicine Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Precision Medicine Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Precision Medicine (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Precision Medicine (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Precision Medicine (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Precision Medicine (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Precision Medicine (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Precision Medicine (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Precision Medicine (Big Data Analytics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Precision Medicine (Big Data Analytics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Precision Medicine (Bioinformatics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Precision Medicine (Bioinformatics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Precision Medicine (Gene Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Precision Medicine (Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Precision Medicine (Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Precision Medicine (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Precision Medicine (Companion Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Precision Medicine (Companion Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Precision Medicine (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Precision Medicine (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Precision Medicine (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Precision Medicine (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Precision Medicine (Central Nervous System-CNS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Precision Medicine (Central Nervous System-CNS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Precision Medicine (Immunology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Precision Medicine (Immunology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Precision Medicine (Respiratory Medicine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Precision Medicine (Respiratory Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Precision Medicine (Infections) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Precision Medicine (Infections) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Precision Medicine (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Precision Medicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Precision Medicine (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Precision Medicine (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Precision Medicine (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Precision Medicine (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Precision Medicine (Pharma and Biotech Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Precision Medicine (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Precision Medicine (Healthcare IT Firms) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Precision Medicine (Healthcare IT Firms) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Global: Precision Medicine (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Precision Medicine (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: North America: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: North America: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: United States: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: United States: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Canada: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Canada: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Asia-Pacific: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Asia-Pacific: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: China: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: China: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Japan: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Japan: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: India: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: India: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: South Korea: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: South Korea: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Australia: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Australia: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Indonesia: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Indonesia: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Others: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Others: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Europe: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Europe: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Germany: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Germany: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: France: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: France: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: United Kingdom: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: United Kingdom: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Italy: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Italy: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Spain: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Spain: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Russia: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Russia: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Others: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Others: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Latin America: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Latin America: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Brazil: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Brazil: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Mexico: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Mexico: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Others: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Others: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Middle East and Africa: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Middle East and Africa: Precision Medicine Market: Breakup by Country (in %), 2022
  • Figure 97: Middle East and Africa: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 98: Global: Precision Medicine Industry: SWOT Analysis
  • Figure 99: Global: Precision Medicine Industry: Value Chain Analysis
  • Figure 100: Global: Precision Medicine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Precision Medicine Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Precision Medicine Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Precision Medicine Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Precision Medicine Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Precision Medicine Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Precision Medicine Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Precision Medicine Market: Competitive Structure
  • Table 8: Global: Precision Medicine Market: Key Players